Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm-tail PG-rich repeat-containing protein 2 (STPG2) is a protein encoded by the STPG2 gene located on human chromosome 4[3][5][1]. It is classified as a structural protein, likely involved in the proper formation or function of the sperm tail, although its precise biological role remains unclear beyond its expression and predicted structure[8][3]. No evidence suggests it functions as a receptor, enzyme, transporter, or transcription factor. Genetic variants in STPG2 have been associated with rare syndromes such as Floating-Harbor Syndrome and Sotos Syndrome 2, implicating possible developmental roles, but the protein is not currently considered a direct therapeutic or pharmacological target[3][5][8]. No drugs, biomarkers, or safety concerns are linked to this protein in the therapeutic context[3][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm-tail PG-rich repeat-containing protein 2 (STPG2).